Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II.
Tumlin JA, Murugan R, Deane AM, Ostermann M, Busse LW, Ham KR, Kashani K, Szerlip HM, Prowle JR, Bihorac A, Finkel KW, Zarbock A, Forni LG, Lynch SJ, Jensen J, Kroll S, Chawla LS, Tidmarsh GF, Bellomo R; Angiotensin II for the Treatment of High-Output Shock 3 (ATHOS-3) Investigators. Tumlin JA, et al. Among authors: finkel kw. Crit Care Med. 2018 Jun;46(6):949-957. doi: 10.1097/CCM.0000000000003092. Crit Care Med. 2018. PMID: 29509568 Free PMC article.
Efficacy and safety of renal tubule cell therapy for acute renal failure.
Tumlin J, Wali R, Williams W, Murray P, Tolwani AJ, Vinnikova AK, Szerlip HM, Ye J, Paganini EP, Dworkin L, Finkel KW, Kraus MA, Humes HD. Tumlin J, et al. Among authors: finkel kw. J Am Soc Nephrol. 2008 May;19(5):1034-40. doi: 10.1681/ASN.2007080895. Epub 2008 Feb 13. J Am Soc Nephrol. 2008. PMID: 18272842 Free PMC article. Clinical Trial.
Plasma inflammatory and apoptosis markers are associated with dialysis dependence and death among critically ill patients receiving renal replacement therapy.
Murugan R, Wen X, Shah N, Lee M, Kong L, Pike F, Keener C, Unruh M, Finkel K, Vijayan A, Palevsky PM, Paganini E, Carter M, Elder M, Kellum JA; Biological Markers for Recovery of Kidney (BioMaRK) Study Investigators. Murugan R, et al. Nephrol Dial Transplant. 2014 Oct;29(10):1854-64. doi: 10.1093/ndt/gfu051. Epub 2014 Mar 11. Nephrol Dial Transplant. 2014. PMID: 24619058 Free PMC article.
Associations between Intensity of RRT, Inflammatory Mediators, and Outcomes.
Murugan R, Wen X, Keener C, Pike F, Palevsky PM, Unruh M, Finkel K, Vijayan A, Elder M, Chen YF, Kellum JA; Biological Markers of Recovery for the Kidney (BioMaRK) Study Investigators. Murugan R, et al. Clin J Am Soc Nephrol. 2015 Jun 5;10(6):926-33. doi: 10.2215/CJN.04560514. Epub 2015 Apr 10. Clin J Am Soc Nephrol. 2015. PMID: 25862777 Free PMC article. Clinical Trial.
A Multi-Center, Randomized, Controlled, Pivotal Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device in Patients with Acute Kidney Injury.
Tumlin JA, Galphin CM, Tolwani AJ, Chan MR, Vijayan A, Finkel K, Szamosfalvi B, Dev D, DaSilva JR, Astor BC, Yevzlin AS, Humes HD; SCD Investigator Group. Tumlin JA, et al. PLoS One. 2015 Aug 5;10(8):e0132482. doi: 10.1371/journal.pone.0132482. eCollection 2015. PLoS One. 2015. PMID: 26244978 Free PMC article. Clinical Trial.
70 results